Van Cutsem E.Li C.-P.Nowara E.Aprile G.Moore M.Federowicz I.Van Laethem J.-L.CHIUN HSUTham C.K.Stemmer S.M.Lipp R.Zeaiter A.Fittipaldo A.Csutor Z.Klughammer B.Meng X.Ciuleanu T.2022-08-192022-08-1920140007-0920https://www.scopus.com/inward/record.uri?eid=2-s2.0-84927176540&doi=10.1038%2fbjc.2014.494&partnerID=40&md5=40db51c21963fa2527614d81a84fbd4chttps://scholars.lib.ntu.edu.tw/handle/123456789/617147[SDGs]SDG3Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: The phase II RACHEL studyjournal article10.1038/bjc.2014.494252473182-s2.0-84927176540